Total Payments
$868.43
2024 Payments
$173.34
Companies
14
Transactions
57
Medicare Patients
13,700
Medicare Billing
$544,227
Payment Breakdown by Category
Food & Beverage$868.43 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $868.43 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $349.28 | 24 | $0 (2024) |
| Amgen Inc. | $157.82 | 10 | $0 (2024) |
| Abbott Laboratories | $95.93 | 5 | $0 (2024) |
| Lilly USA, LLC | $46.11 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $40.87 | 3 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $38.32 | 2 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $34.54 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $24.70 | 2 | $0 (2022) |
| Currax Pharmaceuticals LLC | $15.32 | 1 | $0 (2021) |
| Esperion Therapeutics, Inc. | $14.30 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $173.34 | 10 | Amgen Inc. ($64.08) |
| 2023 | $98.66 | 7 | Novo Nordisk Inc ($84.30) |
| 2022 | $208.31 | 14 | Novo Nordisk Inc ($122.82) |
| 2021 | $388.12 | 26 | Novo Nordisk Inc ($111.17) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Diabetes Care | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 04/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 10/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Obesity | ||||||
| 08/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 07/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 06/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 03/22/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Obesity | ||||||
| 01/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.65 | General |
| 11/03/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.25 | General |
| 09/12/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Obesity | ||||||
| 08/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Cardio-renal | ||||||
| 07/29/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.62 | General |
| 06/27/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Obesity | ||||||
| 05/17/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Inflammation | ||||||
| 04/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardio-renal | ||||||
| 04/23/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,910 | 3,392 | $324,257 | $115,425 |
| 2022 | 37 | 3,577 | 4,174 | $396,603 | $137,288 |
| 2021 | 39 | 3,639 | 4,127 | $400,383 | $150,999 |
| 2020 | 39 | 3,574 | 4,203 | $408,167 | $140,514 |
Total Patients
13,700
Total Services
15,896
Medicare Billing
$544,227
Procedure Codes
150
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 311 | 311 | $88,635 | $32,285 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 375 | $78,750 | $25,519 | 32.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 61 | 61 | $30,256 | $17,247 | 57.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 403 | 521 | $13,025 | $4,376 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 61 | 61 | $4,880 | $4,374 | 89.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 276 | 294 | $13,230 | $3,857 | 29.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 216 | 257 | $8,995 | $2,447 | 27.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 193 | 217 | $13,020 | $2,246 | 17.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $6,400 | $2,126 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 68 | $3,740 | $1,984 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 43 | $6,450 | $1,944 | 30.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 106 | 118 | $7,080 | $1,942 | 27.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 195 | 227 | $5,675 | $1,882 | 33.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 64 | 64 | $3,520 | $1,867 | 53.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,760 | $1,702 | 29.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 38 | 42 | $2,940 | $1,699 | 57.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,025 | $1,465 | 48.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 94 | 110 | $4,400 | $837.10 | 19.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 17 | $2,040 | $750.79 | 36.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 20 | 23 | $1,725 | $667.23 | 38.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 59 | 64 | $3,200 | $565.76 | 17.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 30 | 38 | $1,786 | $507.68 | 28.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 74 | 82 | $1,640 | $464.12 | 28.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 73 | 80 | $2,800 | $406.40 | 14.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 24 | 26 | $1,170 | $384.28 | 32.8% |
About Jesse Myers
Jesse Myers is a Physician Assistant healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1356849111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jesse Myers has received a total of $868.43 in payments from pharmaceutical and medical device companies, with $173.34 received in 2024. These payments were reported across 57 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($868.43).
As a Medicare-enrolled provider, Myers has provided services to 13,700 Medicare beneficiaries, totaling 15,896 services with total Medicare billing of $544,227. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Leland, NC
- Active Since 01/26/2018
- Last Updated 03/17/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1356849111
Products in Payments
- Ozempic (Drug) $106.79
- Otezla (Drug) $106.48
- Saxenda (Drug) $62.48
- Wegovy (Drug) $59.75
- Aimovig (Biological) $51.34
- FreeStyle Libre (Device) $48.96
- FREESTYLE LIBRE 3 (Device) $46.97
- Vascepa (Drug) $40.87
- NURTEC ODT (Drug) $38.32
- MOUNJARO (Drug) $31.30
- Rybelsus (Drug) $31.14
- Kerendia (Drug) $24.70
- Edarbi (Drug) $20.09
- CONTRAVE (Drug) $15.32
- JARDIANCE (Drug) $14.81
- Horizant (Drug) $14.45
- NEXLETOL (Drug) $14.30
- LOREEV XR (Drug) $13.79
- UBRELVY (Drug) $13.53
- BELSOMRA (Drug) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Leland
Emily Crosson, Pa-C, PA-C
Physician Assistant — Payments: $2,266
Physician Assistant $2,266
Chad Snow, Pa, PA
Physician Assistant — Payments: $994.86
Physician Assistant $994.86
Ms. Stephanie Collins, Pa-C, PA-C
Physician Assistant — Payments: $991.46
Physician Assistant $991.46
Jenna Hester, Pa-C, PA-C
Physician Assistant — Payments: $805.68
Physician Assistant $805.68
Allison Hindt, Pa-C, PA-C
Physician Assistant — Payments: $635.32
Physician Assistant $635.32
Karis Van Althuis, Pa-C, PA-C
Physician Assistant — Payments: $629.08
Physician Assistant $629.08